Grant: CIHR Clinician Scientist - Phase 1
Direct Payment
$187,500.00
Identification of signaling pathways driving leukemic stem cell fitness in murine models of leukemia development
EF 2012-13
Résumé
Cancer in humans is often the result of the accumulation of genetic damage over years. Many people seek medical attention with conditions called "pre-cancerous", in the sense that they are known to transform into an aggressive cancer over time. For many of these patients, there is currently no better course of action than observation. The goal of this project is to monitor the evolution of "pre-leukemic" cells in mice over time, as they eventually transform into a disease that makes the mouse sick. I am interested in learning how these cells gradually learn to "escape" the control of their environment in order to become aggressive. This model could be applied to other types of cancer. I hope to have a positive impact on human disease. By better understanding the transformation of pre-cancerous lesions into aggressive cancer, it might be possible to develop new treatments or monitoring tools for patient affected with these conditions.
Programme
CIHR Clinician Scientist - Phase 1
Bénéficiaire
Emplacement
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
277921
Name
Mercier François
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Clinician Scientist
Projecttitle
Identification of signaling pathways driving leukemic stem cell fitness in murine models of leukemia development
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$187,500
Cihrequipment2
$0
Programname2
CIHR Clinician Scientist - Phase 1
Keyworddelim
Cancer Genetics; Dna Sequencing; Flow Cytometry; Gene Expression Profiline; Leukemia; Murine Models Of Cancer; Stem Cell Biology
Abstract
Cancer in humans is often the result of the accumulation of genetic damage over years. Many people seek medical attention with conditions called "pre-cancerous", in the sense that they are known to transform into an aggressive cancer over time. For many of these patients, there is currently no better course of action than observation. The goal of this project is to monitor the evolution of "pre-leukemic" cells in mice over time, as they eventually transform into a disease that makes the mouse sick. I am interested in learning how these cells gradually learn to "escape" the control of their environment in order to become aggressive. This model could be applied to other types of cancer. I hope to have a positive impact on human disease. By better understanding the transformation of pre-cancerous lesions into aggressive cancer, it might be possible to develop new treatments or monitoring tools for patient affected with these conditions.
Competitiondate
201301
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mercier, François
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $187,500~ $0~